Ambarish Dash is a debt finance partner in the London office of Kirkland & Ellis International LLP. Ambarish represents financial sponsors and their portfolio companies on a wide range of complex financings with a focus on domestic and cross-border syndicated credit, acquisition finance and other leveraged finance transactions.
Experience
Representative Matters
Since joining Kirkland, Ambarish’s experience has included advising:
Thoma Bravo and its portfolio company Veriforce on the acquisition of CHAS
Thoma Bravo on its take-private acquisition of Mercell Holding
Triton Partners on the sale of Ewellix
Main Street Capital on the financing for the acquisition of Critical Mention
Noble Group on the successful $1.3 billion financial restructuring of its trading business
EW Healthcare Partners and other shareholders on the €750 million sale of EUSA Pharma to Recordati
NortonLifeLock on its c.$25 billion combination with Avast
EW Healthcare Partners on the acquisition of a majority stake in Laboratoires Majorelle
TDR Capital on the acquisition of BPP
HGGC on the sale of a majority stake in Davies
Bain Capital Credit on its entry into a strategic partnership with Beat Capital Partners Ltd
Thoma Bravo on the £3.1 billion recommended cash offer for Sophos
Atnahs Pharma on the acquisition of established hypertension medicines from AztraZeneca
Triton Partners on the financing of its acquisition of Atnahs Pharma
Altor Equity Partners and its portfolio company CTEK in connection with the refinancing of CTEK’s existing financing arrangements
Lion Capital on the financing aspects of its acquisition of Crafts Group Limited
Prior to joining Kirkland, Ambarish’s experience includes advising:
KKR:
in the financing of its acquisition of Unilever’s spreads business
in the financing of its acquisition of TUI’s Travelopia division
in connection with GenesisCare’s first European syndicated financing
in the financing aspects of its acquisition of Hilding Anders
Apax Partners:
in the financing of its acquisition and consolidation of Invent Farma and NuPharm (rebranded Neuraxpharm)
in the financing of its acquisition of EVRY; and advising EVRY in its subsequent post-IPO refinancing
in the financing of its acquisition of Azelis; and advising Azelis in its subsequent acquisition by EQT
in the refinancing of Apax-owned Top Right Group (rebranded Ascential); and advising Ascential in its subsequent post-IPO refinancing
in the financing of the acquisition of Solita by the Apax Digital Fund
Blackstone:
in the financing of the acquisition of PennWell Corp. by Blackstone-owned Clarion Events
in the financing aspects of its acquisition of Ideal Shopping Direct
Melrose plc in the financing of its public to private acquisition of GKN plc
Apax Partners, Blackstone and KKR in the financing aspects of various acquisition bids
Prior Experience
Simpson Thacher & Bartlett LLP
Associate (2014–2018)
Allen & Overy LLP
Associate (2013–2014)
Trainee Solicitor (2011–2013)
More
Credentials
Admissions & Qualifications
2013, Admitted to Practice as a Solicitor of England and Wales
